A Multicenter, Randomized, Single-blind, Parallel Controlled Clinical Study on the Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy
Latest Information Update: 27 Dec 2022
Price :
$35 *
At a glance
- Drugs Remimazolam (Primary) ; Propofol
- Indications Sedation
- Focus Therapeutic Use
- 12 Dec 2022 Trial design, published in the Trials
- 07 Oct 2022 Planned End Date changed from 1 Aug 2022 to 1 Aug 2023.
- 07 Oct 2022 Planned primary completion date changed from 1 Jul 2022 to 1 Jul 2023.